CORRECTION article
Front. Chem., 26 November 2019
Sec. Medicinal and Pharmaceutical Chemistry
Volume 7 - 2019 | https://doi.org/10.3389/fchem.2019.00804
RETRACTED: Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents
- HA
H. A. Arjun 1
- RE
Ramakrishnan Elancheran 1
- NM
N. Manikandan 2
- KL
K. Lakshmithendral 1
- MR
Muthiah Ramanathan 2
- AB
Atanu Bhattacharjee 3
- NK
N. K. Lokanath 4
- SK
Senthamaraikannan Kabilan 1*
1. Drug Discovery Lab, Department of Chemistry, Annamalai University, Chidambaram, India
2. Department of Pharmacology, PSG College of Pharmacy, Coimbatore, India
3. Computational Biology Laboratory, Department of Biotechnology & Bioinformatics, North Eastern Hill University, Shillong, India
4. Department of Physics, University of Mysore, Mysore, India
Summary
Citation
Arjun HA, Elancheran R, Manikandan N, Lakshmithendral K, Ramanathan M, Bhattacharjee A, Lokanath NK and Kabilan S (2019) RETRACTED: Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents. Front. Chem. 7:804. doi: 10.3389/fchem.2019.00804
Received
23 October 2019
Accepted
07 November 2019
Published
26 November 2019
Volume
7 - 2019
Edited and reviewed by
Greta Varchi, Consiglio Nazionale delle Ricerche (Bologna), Italy
Updates
This article was submitted to Medicinal and Pharmaceutical Chemistry, a section of the journal Frontiers in Chemistry
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.